Keywords: Bilthoven Biologicals, Serum Institute of India, Poonawalla Group, M&A, Vaccines, MAbs

Bilthoven Biologicals acquired by Serum Institute of India

Article | 06 July 2012

Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that it has been acquired by Serum ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in